Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1)

Gene

Volumn 233, Issue 1-2, 1999, Pages 21-31

  Gong, Maokai ^a   Cowan, Kenneth H ^a   Gudas, Jean ^a   Moscow, Jeffrey A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell cycle regulation; Leucovorin; Methotrexate; Trimetrexate

Indexed keywords

CARRIER PROTEIN; DNA FRAGMENT; FOLATE BINDING PROTEIN; METHOTREXATE;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; EXON; GENE CONTROL; GENE ISOLATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TRANSFORMED; DNA PRIMERS; EXONS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTRONS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; PROMOTER REGIONS (GENETICS); RNA;

EID: 0032807628     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00166-3     Document Type: Article

References (36)

1. Badr M.Z., Chen T.S. Prevention of methotrexate-induced gastrointestinal toxicity by glucose. Drug Nutr. Interact. 5:1987;43-47.
2. Brigle K.E., Spinella M.J., Sierra E.E., Goldman I.D. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line. J. Biol. Chem. 270:1995;22 974-22 979.
3. Burger C., Wick M., Brusselbach S., Mueller R. Differential induction of 'metabolic genes' after mitogen stimulation and during normal cell cycle progression. J. Cell Sci. 107:1994;241-252.
4. Chello P.L., Sirotnak F.M., Dorick D.M. Alterations in the kinetics of methotrexate transport during growth of L1210 murine leukemia cells in culture. Mol. Pharmacol. 18:1980;274-280.
5. Cowan K.H., Jolivet J. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. J. Biol. Chem. 259:1984;10 793-10 800.
6. Dixon K.H., Trepel J.B., Eng S.C., Cowan K.H. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Cancer Commun. 3:1991;357-365.
7. Dixon K.H., Lanpher B.C., Chiu J., Kelley K., Cowan K.H. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem. 269:1994;17-20.
8. Drake J.C., Allegra C.J., Moran R.G., Johnston P.G. Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines. Biochem. Pharmacol. 51:1996;1349-1355.
9. Ethier S.P., Mahacek M.L., Gullick W.J., Frank T.S., Weber B.L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites. Cancer Res. 53:1993;627-635.
10. Fisher G.A. Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. Biochem. Pharmacol. 11:1960;1233-1234.
11. Flintoff W.F., Essani K. Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry. 18:1980;4321-4327.
12. Goldman I.D., Lichtenstein N.S., Oliverio V.T. Carrier-mediated transport of the folic acid analogue, methotrexate, in L1210 leukemia. J. Biol. Chem. 243:1968;5007-5017.
13. Gong M.K., Yess J., Connolly T., Ivy S.P., Ohnuma T., Cowan K.H., Moscow J.A. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 cell line. Blood. 89:1997;2494-2499.
14. Gorlick R., Goker E., Trippet T., Steinherz P., Elisseyeff Y., Mazumdar M., Flintoff W.F., Bertino J.R. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood. 89:1997;1013-1018.
15. Gudas J.M., Knight G.B., Pardee A.B. Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. Proc. Natl. Acad. Sci. USA. 85:1988;4705-4709.
16. Gudas J.M., Nguyen H., Li T., Sadzewicz L., Robey R., Wosikowski K., Cowan K.H. Drug-resistant breast cancer cells frequently retain expression of wild-type p53 protein. Carcinogenesis. 17:1996;1417-1427.
17. Henderson G.B., Zevely E.M. Transport of methotrexate in L1210 cells: effect of ions on the rate and extent of uptake. Arch. Biochem. Biophys. 200:1980;149-155.
18. Henderson G.B., Zevely E.M. Transport routes utilized by L1210 cells for the influx and efflux of methotrexate. J. Biol. Chem. 259:1984;1526-1531.
19. Henderson G.B., Zevely E.M., Huennekens F.M. Irreversible inactivation of the methotrexate transport system of L1210 cells by carbodiimide-activated substrates. J. Biol. Chem. 255:1980;4829-4833.
20. Hoffbrand A.V., Tripp E., Catovsky D., Das K.C. Transport of methotrexate into normal hematopoietic cells and into leukemic cells and its effects on DNA synthesis. Brit. J. Haematol. 25:1973;497-511.
21. Marzluff W.F., Pandey N.B. Multiple regulatory steps control histone mRNA concentrations. Trends Biochem. 13:1988;49-52.
22. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:1982;7895-7903.
23. Moscow J.A. Methotrexate transport and resistance. Leukemia Lymphoma. 1998;. in press.
24. Moscow J.A., Gong M., He R., Sgagias M.K., Dixon K.H., Anzick S.L., Meltzer P.S., Cowan K.H. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55:1995;3790-3794.
25. Moscow J.A., Connolly T., Myers T., Paull K., Cheng C.C., Cowan K.H. Reduced folate carrier gene expression in transfected and non-selected cell lines. Int. J. Cancer. 72:1997;184-190.
26. Ohnuma T., Lo R.J., Scanlon K.J., Kamen B.A., Ohnoshi T., Wolman S.R., Holland J.F. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Cancer Res. 45:1985;1815-1822.
27. Prasad P.D., Ramamoorthy S., Leibach F.H., Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem. Biophys. Res. Commun. 206:1995;681-687.
28. Schilling L.J., Farnham P.J. Inappropriate transcription from the 5′ end of the murine dihydrofolate reductase gene masks transcriptional regulation. Nucleic Acids Res. 22:1994;3061-3068.
29. Sirotnak F.M., Kurita F.M., Hutchison D.J. On the nature of a transport alteration detemining resistance to amethopterin in the L1210 leukemia. Cancer Res. 28:1968;75-80.
30. Tolner B., Roy K., Sirotnak F.M. Structural analuysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity. Gene. 211:1998;331-341.
31. Williams F.M., Flintoff W.F. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J. Biol. Chem. 270:1995;2987-2992.
32. Williams F.R.M., Maurray R.C., Underhill T.M., Flintoff W.F. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J. Biol. Chem. 269:1994;5810-5816.
33. Wong S.C., Proefke S.A.A.B., Matherly L.H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-deficient Chinese hamster ovary cells. J. Biol. Chem. 270:1995;17 468-17 475.
34. Zhang L., Taub J.W., Williamson M., Wong S.C., Hukku B., Pullen J., Ravindranath Y., Matherly L.H. Reduced folate carrier expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin. Cancer Res. 4:1998;2169-2177.
35. Zhang L., Wong S.C., Matherly L.H. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem. J. 332:1998;773-780.
36. Zhao R., Assaraf Y.G., Goldman I.D. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5- formyltetrahydrofolate. J. Biol. Chem. 273:1998;7873-7879.